Dasatinib-d4

(Synonyms: BMS-354825-d4)

Dasatinib-d4 (BMS-354825-d4) is deuterium labeled Dasatinib. Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively. Dasatinib also induces apoptosis and autophagy.

For research use only. We do not sell to patients.

  • Purity: 97.54%
  • CAS No.: 1160297-08-4
  • Formula: C22H22D4ClN7O2S
  • Molecular Weight:492.03
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Bcr-Abl Isoforms

More

All Src Isoforms

More
100 mg
Get Quote In-stock
Please select quantity
Price: USD 0.00